Triamcinolone (intraocular formulations) : List of nationally authorised medicinal products - PSUSA/00010292/202303
Triamcinolone (intraocular formulations) : List of nationally authorised medicinal products - PSUSA/00010292/202303
Triamcinolone (intraocular formulations) : List of nationally authorised medicinal products - PSUSA/00010292/202303
Mometasone furoate/olopatadine : List of nationally authorised medicinal products - PSUSA/00010957/202304
human plasma (pooled and treated for virus inactivation) : List of nationally authorised medicinal products - PSUSA/00001635/202302
Plasma master file certificates
Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) Multistakeholder workshop on Patient Registries, European Medicines Agency, Amsterdam, the Netherlands, from 12/02/2024 to 13/02/2024
Human medicines European public assessment report (EPAR): Qutenza, capsaicin, Date of authorisation: 15/05/2009, Revision: 19, Status: Authorised
EMEA-002545-PIP01-19-M01
Opinion/decision on a Paediatric investigation plan (PIP): Atropine (sulfate), decision type: , therapeutic area: , PIP number: P/0416/2022
EMEA-002350-PIP04-21
EMEA-001468-PIP01-13